Evolva Holding SA
Company Snapshot
Company Overview
Evolva, formerly Allylix, has developed proprietary technology that allows it to produce a group of natural products called “terpenes” at a low cost. Terpenes have significant commercial value to the flavor and fragrance, insect repellent and pharmaceutical industries.
Evolva initially focused on a class of terpenes called “sesquiterpenes,” which are part of the $2-billion aroma chemical segment of the flavor and fragrance market. Evolva’s technology utilizes metabolically engineered S. cerevisiae yeast expressing sesquiterpene synthases to produce sesquiterpenes.
Evolva has identified numerous sesquiterpene flavors and fragrances whose markets would expand substantially if there were low-cost alternatives. Evolva’s first two products are the grapefruit flavor nootkatone and the orange flavor valencene, which went on the market in December 2010.
Evolva also plans to develop four sesquiterpene fragrances that are highly valued by perfumers but have Ltd. use due to their high prices. The company plans to produce these six important fragrances at a cost that will allow them to be used in household and personal care products.
In the long term, Evolva will explore the potential to capture value from its technology in the pharmaceutical market through sales of novel pharmaceutical intermediates or the development of new drugs.
Evolva Holding SA In News
Applications/End User Industries
- Biotechnology
- Nutrition
- Health and Wellness
- Technology Services
- Health Protection